中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2015年
4期
701-704
,共4页
杨常顺%李伟华%蔡少鑫%王欢%王乐%周飙寰
楊常順%李偉華%蔡少鑫%王歡%王樂%週飆寰
양상순%리위화%채소흠%왕환%왕악%주표환
K-ras基因%鼠类肉瘤滤过性毒菌致癌同源体B1基因%基因突变%结直肠癌
K-ras基因%鼠類肉瘤濾過性毒菌緻癌同源體B1基因%基因突變%結直腸癌
K-ras기인%서류육류려과성독균치암동원체B1기인%기인돌변%결직장암
K-ras gene%v-raf murine sarcoma viral oncogene homolog B1 gene%Gene mutation%Colorectal caner
目的 探讨K-ras、鼠类肉瘤滤过性毒菌致癌同源体B1 (BRAF)基因在结直肠癌中突变特征及其临床意义.方法 采用实时定量聚合酶链反应(Real-time PCR)法检测412例结直肠癌组织K-ras、BRAF基因常见密码子突变特征,分析K-ras、BRAF突变与结直肠癌临床病理特征的关系.结果 412例结直肠癌K-ras基因突变率为37.9%,直肠癌K-ras基因突变率为45.2%,高于结肠癌(28.8%,P <0.05).K-ras基因突变中单个位点突变率为35.4%,2个位点的突变率为2.2%,3个位点突变率为0.2%.K-ras突变常见于12和13位密码子,12位密码子占32.0%,分别为G12D(15.0%)、G12V(9.5%)、G12C(3.9%)、G12S (2.9%)、G12A(2.4%)和G12R (0.7%),13位密码子占6.1%,均为G13D.K-ras基因突变方式以G→A为主.Ⅰ+Ⅱ期结直肠癌K-ras基因突变率(30.4%)低于Ⅲ+Ⅳ期(45.2%,P<0.05),基因位点突变分析只发现G12V突变率在TNM分期Ⅰ+Ⅱ期的突变率(5.9%)低于Ⅲ+Ⅳ期(13.0%,P<0.05).K-ras基因突变与性别、年龄、肿瘤大小、肿瘤大体类型、组织学分型以及淋巴结转移等临床病理参数无关(P>0.05).结直肠癌中BRAFV600E基因突变率为2.4%,其中结肠癌中的BRAF基因的突变率(4.9%)高于直肠癌(0.4%,P<0.05).结论 在结直肠癌中,K-ras基因突变以单个位点突变为主,其中又以G12D最为常见,其中G12V突变可能与结直肠癌进展相关.直肠癌K-ras突变率高于结肠癌,而结肠癌BRAF突变率高于直肠癌.K-ras、BRAF基因突变在结肠癌和直肠癌中的作用机制可能不同.
目的 探討K-ras、鼠類肉瘤濾過性毒菌緻癌同源體B1 (BRAF)基因在結直腸癌中突變特徵及其臨床意義.方法 採用實時定量聚閤酶鏈反應(Real-time PCR)法檢測412例結直腸癌組織K-ras、BRAF基因常見密碼子突變特徵,分析K-ras、BRAF突變與結直腸癌臨床病理特徵的關繫.結果 412例結直腸癌K-ras基因突變率為37.9%,直腸癌K-ras基因突變率為45.2%,高于結腸癌(28.8%,P <0.05).K-ras基因突變中單箇位點突變率為35.4%,2箇位點的突變率為2.2%,3箇位點突變率為0.2%.K-ras突變常見于12和13位密碼子,12位密碼子佔32.0%,分彆為G12D(15.0%)、G12V(9.5%)、G12C(3.9%)、G12S (2.9%)、G12A(2.4%)和G12R (0.7%),13位密碼子佔6.1%,均為G13D.K-ras基因突變方式以G→A為主.Ⅰ+Ⅱ期結直腸癌K-ras基因突變率(30.4%)低于Ⅲ+Ⅳ期(45.2%,P<0.05),基因位點突變分析隻髮現G12V突變率在TNM分期Ⅰ+Ⅱ期的突變率(5.9%)低于Ⅲ+Ⅳ期(13.0%,P<0.05).K-ras基因突變與性彆、年齡、腫瘤大小、腫瘤大體類型、組織學分型以及淋巴結轉移等臨床病理參數無關(P>0.05).結直腸癌中BRAFV600E基因突變率為2.4%,其中結腸癌中的BRAF基因的突變率(4.9%)高于直腸癌(0.4%,P<0.05).結論 在結直腸癌中,K-ras基因突變以單箇位點突變為主,其中又以G12D最為常見,其中G12V突變可能與結直腸癌進展相關.直腸癌K-ras突變率高于結腸癌,而結腸癌BRAF突變率高于直腸癌.K-ras、BRAF基因突變在結腸癌和直腸癌中的作用機製可能不同.
목적 탐토K-ras、서류육류려과성독균치암동원체B1 (BRAF)기인재결직장암중돌변특정급기림상의의.방법 채용실시정량취합매련반응(Real-time PCR)법검측412례결직장암조직K-ras、BRAF기인상견밀마자돌변특정,분석K-ras、BRAF돌변여결직장암림상병리특정적관계.결과 412례결직장암K-ras기인돌변솔위37.9%,직장암K-ras기인돌변솔위45.2%,고우결장암(28.8%,P <0.05).K-ras기인돌변중단개위점돌변솔위35.4%,2개위점적돌변솔위2.2%,3개위점돌변솔위0.2%.K-ras돌변상견우12화13위밀마자,12위밀마자점32.0%,분별위G12D(15.0%)、G12V(9.5%)、G12C(3.9%)、G12S (2.9%)、G12A(2.4%)화G12R (0.7%),13위밀마자점6.1%,균위G13D.K-ras기인돌변방식이G→A위주.Ⅰ+Ⅱ기결직장암K-ras기인돌변솔(30.4%)저우Ⅲ+Ⅳ기(45.2%,P<0.05),기인위점돌변분석지발현G12V돌변솔재TNM분기Ⅰ+Ⅱ기적돌변솔(5.9%)저우Ⅲ+Ⅳ기(13.0%,P<0.05).K-ras기인돌변여성별、년령、종류대소、종류대체류형、조직학분형이급림파결전이등림상병리삼수무관(P>0.05).결직장암중BRAFV600E기인돌변솔위2.4%,기중결장암중적BRAF기인적돌변솔(4.9%)고우직장암(0.4%,P<0.05).결론 재결직장암중,K-ras기인돌변이단개위점돌변위주,기중우이G12D최위상견,기중G12V돌변가능여결직장암진전상관.직장암K-ras돌변솔고우결장암,이결장암BRAF돌변솔고우직장암.K-ras、BRAF기인돌변재결장암화직장암중적작용궤제가능불동.
Objective To investigate mutations of K-ras and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) genes in colorectal cancer and their clinical significance.Methods 412 cases of colorectal cancer tissue specimens were selected.Real-time quantitative polymerase chain reaction (Real-time PCR) was used to study the characteristics of K-ras and BRAF gene mutation sites and their relationship with clinicopathologic parameters.Results In 412 cases,the mutation rate of K-ras gene was 37.9%.The K-ras mutation rate in rectal cancer (45.2%) was higher than in colon cancer (28.8%,P<0.05).The rate of single locus mutation was 35.4%,while the rate of double locus mutation was 2.2% and the rate of triple locus mutation was 0.2%.The K-ras mutation was most commonly located in codons 12 and 13,in which the rate of codon 12 was 32.0%.The mutation patterns of codon 12 included G12D (15.0%),G12V (9.5%),G12C (3.9%),G12S (2.9%),G12A (2.4%) and G12R (0.7%).The mutation pattern of thre codon 13 was G13D (6.1%).G→A was the most common mutation pattern.The K-ras gene mutation rate of Ⅰ + Ⅱ stage (30.4%) was lower than that of Ⅲ + Ⅳ stage (45.2%),with statistically significant difference (P <0.05).Further analysis showed the mutation rate (5.9%) of G12V in TNM stage Ⅰ + Ⅱ was lower than that in stage Ⅲ + Ⅳ (13.0%,P < 0.05).The K-ras mutation was irrelevant to gender,age,tumor size,clinical tumor type,histological classification and lymphatic metastasis.The BRAFV600E mutation rate of colorectal cancer was 2.4%,and that of colon cancer (4.9%) was higher than rectal cancer (0.4%),with statistically significant difference (P < 0.05).Conclusion In colorectal cancer,single locus mutation is most common in K-ras mutation,in which G12D was the main pattern.The mutation status of the G12V can probably promote the progresssion of colorectal cancer.The K-ras mutation rate in rectal cancer was higher than in colon cancer,while the BRAF mutation rate in colon cancer was higher than in rectal cancer.The mechanisms of K-ras and BRAF mutation in colon and rectal cancers may be different.